Warning: The NCBI web site requires JavaScript to function. more...
Trichloroethylene and cancer: epidemiologic evidence
Scott CS, Cogliano VJ.
Environ Health Perspect. 2000 May;108 Suppl 2:159-60.PMID: 10807549 [PubMed - as supplied by publisher]Related articles
Dose-response analyses of the carcinogenic effects of trichloroethylene in experimental animals.
Rhomberg LR.
Environ Health Perspect. 2000 May;108 Suppl 2:343-58. Review.PMID: 10807564 [PubMed - indexed for MEDLINE]Related articlesFree article
Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly.
Evans MV, Chiu WA, Okino MS, Caldwell JC.
Toxicol Appl Pharmacol. 2009 May 1;236(3):329-40. Epub 2009 Feb 26.PMID: 19249323 [PubMed - indexed for MEDLINE]Related articles
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials.
Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. Epub 2008 Feb 13. Review.PMID: 18328408 [PubMed - indexed for MEDLINE]Related articles
Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene.
Clewell HJ, Andersen ME.
Crit Rev Toxicol. 2004 Sep-Oct;34(5):385-445. Review.PMID: 15560567 [PubMed - indexed for MEDLINE]Related articles
Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene.
Moore MM, Harrington-Brock K.
Environ Health Perspect. 2000 May;108 Suppl 2:215-23. Review.PMID: 10807553 [PubMed - indexed for MEDLINE]Related articlesFree article
Evaluating human variability in chemical risk assessment: hazard identification and dose-response assessment for noncancer oral toxicity of trichloroethylene.
Barton HA, Flemming CD, Lipscomb JC.
Toxicology. 1996 Jul 17;111(1-3):271-87. Review.PMID: 8711742 [PubMed - indexed for MEDLINE]Related articles
Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment.
Barton HA, Clewell HJ 3rd.
Environ Health Perspect. 2000 May;108 Suppl 2:323-34. Review.PMID: 10807562 [PubMed - indexed for MEDLINE]Related articlesFree article
Metabolism of trichloroethylene.
Lash LH, Fisher JW, Lipscomb JC, Parker JC.
Environ Health Perspect. 2000 May;108 Suppl 2:177-200. Review.PMID: 10807551 [PubMed - indexed for MEDLINE]Related articlesFree article
Chloroform mode of action: implications for cancer risk assessment.
Golden RJ, Holm SE, Robinson DE, Julkunen PH, Reese EA.
Regul Toxicol Pharmacol. 1997 Oct;26(2):142-55. Review.PMID: 9356278 [PubMed - indexed for MEDLINE]Related articles
Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.
Caldwell JC, Keshava N.
Environ Health Perspect. 2006 Sep;114(9):1457-63. Review.PMID: 16966105 [PubMed - indexed for MEDLINE]Related articlesFree article
Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ.
Chem Biol Interact. 2007 Mar 20;166(1-3):150-5. Epub 2006 Apr 5.PMID: 16647696 [PubMed - indexed for MEDLINE]Related articles
A trichloroethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling.
Cronin WJ 4th, Oswald EJ, Shelley ML, Fisher JW, Flemming CD.
Risk Anal. 1995 Oct;15(5):555-65.PMID: 7501875 [PubMed - indexed for MEDLINE]Related articles
Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses.
Schlosser PM, Lilly PD, Conolly RB, Janszen DB, Kimbell JS.
Risk Anal. 2003 Jun;23(3):473-87.PMID: 12836840 [PubMed - indexed for MEDLINE]Related articles
Pharmacokinetic analysis of trichloroethylene metabolism in male B6C3F1 mice: Formation and disposition of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine.
Kim S, Kim D, Pollack GM, Collins LB, Rusyn I.
Toxicol Appl Pharmacol. 2009 Jul 1;238(1):90-9. Epub 2009 May 3.PMID: 19409406 [PubMed - indexed for MEDLINE]Related articles
Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.
Clewell HJ 3rd, Gentry PR, Covington TR, Gearhart JM.
Environ Health Perspect. 2000 May;108 Suppl 2:283-305. Review.PMID: 10807559 [PubMed - indexed for MEDLINE]Related articlesFree article
Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
Bogen KT, Gold LS.
Regul Toxicol Pharmacol. 1997 Feb;25(1):26-42. Review.PMID: 9056499 [PubMed - indexed for MEDLINE]Related articles
Issues in the pharmacokinetics of trichloroethylene and its metabolites.
Chiu WA, Okino MS, Lipscomb JC, Evans MV.
Environ Health Perspect. 2006 Sep;114(9):1450-6. Review.PMID: 16966104 [PubMed - indexed for MEDLINE]Related articlesFree article
Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration.
Willhite CC, Ball GL, McLellan CJ.
J Toxicol Environ Health B Crit Rev. 2008 Feb;11(2):69-146. Review.PMID: 18188738 [PubMed - indexed for MEDLINE]Related articles
Biomarkers in aquatic plants: selection and utility.
Brain RA, Cedergreen N.
Rev Environ Contam Toxicol. 2009;198:49-109. Review.PMID: 19253039 [PubMed - indexed for MEDLINE]Related articles
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...